76835-20-6

Basic information

• Product Name: 1-(5-Chloro-2-methylphenyl)piperazine
• Synonyms: N-(5-CHLORO-2-METHYLPHENYL)-PIPERAZINE;TIMTEC-BB SBB003438;LABOTEST-BB LTBB000768;AKOS BBS-00003583;1-(5-CHLORO-2-METHYLPHENYL)PIPERAZINE;1-(5-Chloro-2-methylphenyl)-piperazine,98%;1-(5-Chloro-2-methylphenyl)piperazine ,97.5%;1-(5-Chloro-2-Methylphenyl)-piperazine, 98% 50GR
• CAS NO: 76835-20-6
• Molecular Formula: C₁₁H₁₅ClN₂
• Molecular Weight: 210.7
• EINECS: 278-560-2
• Product Categories: API intermediates
• Mol File: 76835-20-6.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 342.56°C (rough estimate)
• Flash Point: 165.1°C
• Appearance: /
• Density: 1.1197 (rough estimate)
• Vapor Pressure: 4.7E-05mmHg at 25°C
• Refractive Index: 1.573-1.576
• PKA: 8.85±0.10(Predicted)
• CAS DataBase Reference: 1-(5-Chloro-2-methylphenyl)piperazine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(5-Chloro-2-methylphenyl)piperazine(76835-20-6)
• EPA Substance Registry System: 1-(5-Chloro-2-methylphenyl)piperazine(76835-20-6)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 37/39-26
• Hazardous Substances Data: 76835-20-6(Hazardous Substances Data)

Usage

Chemical Properties

clear colourless to light yellow liquid

InChI:InChI=1/C11H15ClN2/c1-9-2-3-10(12)8-11(9)14-6-4-13-5-7-14/h2-3,8,13H,4-7H2,1H3/p+1

Upstream product

• 821-48-7 bis-(2-chloroethyl)amine hydrochloride 
• 95-79-4 5-chloro-2-methyl-benzenamine 

Downstream Products

• 548768-63-4 4-(5-Chloro-2-methyl-phenyl)-piperazine-1-carboxylic acid 4-(5-trifluoromethyl-pyridin-2-yloxy)-phenyl ester 
• 1187225-42-8 N-((4-((4-(5-chloro-2-methylphenyl)piperazin-1-yl)methyl)-1H-1,2,3-triazol-5-yl)methyl)-4-iodobenzenesulfonamide 
• 90126-00-4 1-(5-Chloro-2-methyl-phenyl)-4-(2-pyridin-2-yl-ethyl)-piperazine; compound with (E)-but-2-enedioic acid 
• 871338-05-5 1,1-dimethylethyl (2E)-3-[4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]prop-2-enoate 

Relevant articles and documents

Compound with dopamine D3 receptor adjusting activity, and applications thereof

The invention relates to a compound with dopamine D3 receptor adjusting activity, and applications thereof, and more specifically discloses dopamine receptor D3R as a novel target of post-traumatic stress disorder (PTSD) in prevention, treatment/or auxiliary treatment of PTSD, and screening of anti-PTSD medicines, and relates to applications of a compound with dopamine receptor D3R adjusting activity in preparation of medicines used for preventing, treatment and/or auxiliary treatment of PTSD.